Skip to content

Efficacy of "Pain Gear" in Patients With Chronic Musculoskeletal Pain

WithdrawnNCT02974023
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The current study was designed to evaluate the effectiveness and safety of the device in the common areas of the body affected by different causes of musculoskeletal pain in Vietnamese population in real life situation.

Study details

Official title
Efficacy of "Pain Gear" in Patients With Chronic Musculoskeletal Pain
Conditions
  • Chronic Musculoskeletal Disease
Interventions
  • Device: Pain Gear
Sponsor
PharmEvo Pvt Ltd
Collaborators
BioElectronics Corporation
Start date
2017-06-30
Primary completion
2017-10-30
Sex
All
Age range
from 18 Years to 80 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic musculoskeletal pain of more than 6 month duration * Participant is willing and able to give informed consent for participation in the trial. * In the Investigator's opinion, is able and willing to comply with all trial requirements. * Male or female ages 18-80 years old * A current VAS pain rating ≥5/10 * Able to complete and tolerate treatment for the study period. Exclusion Criteria: * Pregnant Woman * Current implanted cardiac demand pacemakers, defibrillators, cardiac pumps, spinal stimulators or other implanted electronic devices. * Patients using personal home based electrical stimulation devices * Active psychiatric disorders (as evidenced by use of antipsychotic or medication). * Patients diagnosed with history of significant mood disorder will be excluded (depression or anxiety with adequate control would be acceptable). * Scheduled elective surgery or other procedures requiring general anesthesia during the trial. * Participant with life expectancy of less than 6 months, or inappropriate for placebo medication. * Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial. * Participants who are not able to understand verbal or written English, and for whom adequate translation/interpretation cannot be readily obtained

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02974023